Opin vísindi

Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli

Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli

Title: Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli
Author: Gudbrandsdottir, Ragna Kristin
Sigurðsson, Engilbert
Ingimarsson, Oddur
Date: 2023-07-01
Language: Icelandic
Scope: 4
Department: Læknadeild
Önnur svið
Series: Læknablaðið; 109(7-8)
ISSN: 1670-4959
DOI: https://doi.org/10.17992/lbl.2023.0708.753
Subject: Geðsjúkdómafræði; ADHD; methylphenidate; psychosis; ADHD; methylphenidate; psychosis; Young Adult; Central Nervous System Stimulants/adverse effects; Humans; Methylphenidate/adverse effects; Male; Psychotic Disorders/diagnosis; Iceland/epidemiology; Attention Deficit Disorder with Hyperactivity/diagnosis; Læknisfræði (allt)
URI: https://hdl.handle.net/20.500.11815/4395

Show full item record


Gudbrandsdottir , R K , Sigurðsson , E & Ingimarsson , O 2023 , ' Geðrof í kjölfar ADHD-lyfjameðferðar : Sjúkratilfelli ' , Læknablaðið , bind. 109 , nr. 7-8 , bls. 346-349 . https://doi.org/10.17992/lbl.2023.0708.753


In view of the ongoing rise of ADHD prescriptions among adults in Iceland, it is important that doctors are aware that psychosis is a rare but at times a serious adverse reaction to such treatment. In 2022 5% of adults were prescribed medication to treat ADHD in Iceland. In this case report we present a case of methylphenidate-induced psychosis in a young man with no previous history of psychotic episodes who required admission to the psychiatric intensive care unit.


Publisher Copyright: © 2023 Laeknafelag Islands. All rights reserved.

Files in this item

This item appears in the following Collection(s)